Anemia hemolítica autoinmune desencadenada por SARS-CoV-2 Reporte de un caso / SARS-CoV-2-Induced Autoimmune Hemolytic Anemia: Case Report
Rev. Fac. Med. UNAM
; 65(1): 26-36, ene.-feb. 2022. tab, graf
Article
de Es
|
LILACS-Express
| LILACS
| ID: biblio-1376288
Bibliothèque responsable:
MX1.1
RESUMEN
Resumen Infection by SARS-CoV-2 virus is not solely limited to the common clinical presentation of acute respiratory distress syndrome, mainly because a wide spectrum of clinical manifestation has been observed. These presentations include, but are not limited to, neurological, cardiovascular, throm- boembolic, hematologic, and autoimmune presentations. Within this wide spectrum, cases of autoimmune hemolytic anemia due to SARS-CoV-2 infection are rising. This is why primary care physicians should be ready to identify this clinical entity appropriately.
ABSTRACT
Abstract Infection by SARS-CoV-2 virus is not solely limited to the common clinical presentation of acute respiratory distress syndrome, mainly because a wide spectrum of clinical manifestation has been observed. These presentations include, but are not limited to, neurological, cardiovascular, throm- boembolic, hematologic, and autoimmune presentations. Within this wide spectrum, cases of autoimmune hemolytic anemia due to SARS-CoV-2 infection are rising. This is why primary care physicians should be ready to identify this clinical entity appropriately.
Texte intégral:
1
Indice:
LILACS
langue:
Es
Texte intégral:
Rev. Fac. Med. UNAM
Thème du journal:
MEDICINA
Année:
2022
Type:
Article